Clinical Trials
5
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
A Feasibility Study to Evaluate the Safety of the KNP-1000 Apheresis System in Severe Preeclampsia
- Conditions
- Pre-Eclampsia, Severe
- First Posted Date
- 2024-08-30
- Last Posted Date
- 2025-03-05
- Lead Sponsor
- Kaneka Medical America LLC
- Target Recruit Count
- 13
- Registration Number
- NCT06580405
Kaneka Endovascular Embolization and Protection
- Conditions
- Aneurysm Cerebral
- First Posted Date
- 2022-10-03
- Last Posted Date
- 2024-03-06
- Lead Sponsor
- Kaneka Medical America LLC
- Target Recruit Count
- 164
- Registration Number
- NCT05563051
- Locations
- 🇺🇸
McLaren Health Care, Grand Blanc, Michigan, United States
🇺🇸Northwell Health Lenox Hill Hospital, New York, New York, United States
🇺🇸Cleveland Clinic, Cleveland, Ohio, United States
Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System
- Conditions
- Focal Segmental Glomerulosclerosis
- First Posted Date
- 2019-08-22
- Last Posted Date
- 2024-10-09
- Lead Sponsor
- Kaneka Medical America LLC
- Target Recruit Count
- 35
- Registration Number
- NCT04065438
- Locations
- 🇺🇸
Loma Linda University Children's Hospital, Loma Linda, California, United States
🇺🇸Loma Linda University Hospital, Loma Linda, California, United States
🇺🇸Nemours/Alfred I DuPont Hospital for Children, Wilmington, Delaware, United States
Post Approval Study of Lixelle for the Treament of Dialysis-Related Amyloidosis
- Conditions
- Dialysis Amyloidosis
- First Posted Date
- 2016-11-02
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- Kaneka Medical America LLC
- Target Recruit Count
- 40
- Registration Number
- NCT02952144
- Locations
- 🇺🇸
The Rogosin Institute, New York, New York, United States
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- Conditions
- Focal Segmental Glomerulosclerosis
- First Posted Date
- 2014-09-10
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- Kaneka Medical America LLC
- Target Recruit Count
- 35
- Registration Number
- NCT02235857
- Locations
- 🇺🇸
Loma Linda University Children's Hospital, Loma Linda, California, United States
🇺🇸Cedars Sinai Medical Center, Los Angeles, California, United States
🇺🇸Nemours/A.I. duPont Hospital for Children, Wilmington, Delaware, United States